Physician

Ajay Mathew, D.O.

According to 2025 Medicare claims, Ajay Mathew, D.O. (NPI: 1346528296) practices nephrology in the Tampa, FL market, with the plurality of this provider's patient population coming from Pasco, FL. This provider's primary affiliated billing organization is OHI WEST MEDICAL GROUP II LLC (NPI: 1982381299; TIN: 923479126) and primary practice location at 33542-7510. Mathew is affiliated with the Florida Medical Clinic ACO, LLC (ACO ID: A1131), participating under the MSSP model.

Mathew's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 469 traditional Medicare patients, billed 2,536 HCPCS/CPT codes, and received $148,632 in Medicare payments. The top billing code was 99223 (Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes). Part D data shows 2,402 prescription claims across 398 beneficiaries totaling $478,133 in drug costs, led by Farxiga (Dapagliflozin Propanediol). DME data shows 81 claims. Open Payments data shows 45 records totaling $1,076. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has changed little. Concurrently, Part D prescription costs have risen steadily, from $1,418 to $478,133. For DME billing, this provider has fewer than 5 years of reported data, so a reliable trend cannot be assigned.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	N/R	N/R	N/R
2016	N/R	N/R	N/R
2017	436	3,182	$119,707
2018	477	1,669	$130,269
2019	501	1,681	$142,042
2020	454	1,720	$142,431
2021	461	1,850	$144,776
2022	486	2,107	$153,115
2023	479	2,166	$162,200
2024	469	2,536	$148,632

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	14	58	$1,418
2016	N/R	12	$1,169
2017	111	319	$24,359
2018	206	828	$310,555
2019	230	1,158	$205,601
2020	234	1,349	$255,438
2021	270	1,502	$127,250
2022	353	1,876	$216,459
2023	394	2,161	$401,149
2024	398	2,402	$478,133

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

Year	Patients	Claims	Payment
2015	N/R	N/R	N/R
2016	N/R	N/R	N/R
2017	N/R	N/R	N/R
2018	N/R	N/R	N/R
2019	N/R	N/R	N/R
2020	N/R	N/R	N/R
2021	N/R	N/R	N/R
2022	N/R	56	$781
2023	N/R	N/R	N/R
2024	N/R	81	$1,193

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
99223	Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes	62	65	$128
99222	Initial hospital care with straightforward or low-level medical decision making, if using time, at least 55 minutes	68	73	$102
99233	Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes	96	176	$92
99214	Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more	214	405	$88
99232	Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes	160	330	$61

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Farxiga	Dapagliflozin Propanediol	150	9,774	$178,174
Velphoro	Sucroferric Oxyhydroxide	30	952	$62,467
Jardiance	Empagliflozin	52	2,830	$53,925
Lokelma	Sodium Zirconium Cyclosilicate	37	2,295	$33,540
Kerendia	Finerenone	16	1,380	$29,005

Top 5 DME services in 2024

By Total Medicare Payment Amount.

HCPCS Code	HCPCS Description	Supplier Rental Indicator	Total Supplier Beneficiaries	Total Supplier Claims	Total Medicare Payment Amount
Q0512	Pharmacy supply fee for oral anti-cancer, oral anti-emetic or immunosuppressive drug(s); for a subsequent prescription in a 30-day period	N	N/R	24	$376
J7507	Tacrolimus, immediate release, oral, 1 mg	N	N/R	16	$294
J7517	Mycophenolate mofetil, oral, 250 mg	N	N/R	16	$288
Q0511	Pharmacy supply fee for oral anti-cancer, oral anti-emetic or immunosuppressive drug(s); for the first prescription in a 30-day period	N	N/R	13	$226
J7512	Prednisone, immediate release or delayed release, oral, 1 mg	N	N/R	12	$9

Open Payments Summary in 2024

Category	Definition	Records	Total Reported Amount	Top Related Entity
General Payments	Reported payment or transfer-of-value amount.	45	$1,076	AstraZeneca Pharmaceuticals LP
Research Payments	Reported research-related payment or transfer-of-value amount.	0	$0	N/R
Ownership / Investment Interests	Reported value of ownership or investment interests.	0	$0	N/R

Explore More Providers

FAQ

What Medicare data is available for Ajay Mathew, D.O.?

Tedicare shows public-source Medicare data for Ajay Mathew, D.O. (NPI 1346528296), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Ajay Mathew, D.O. have ACO affiliation data?

Ajay Mathew, D.O. is shown with ACO affiliation data for Florida Medical Clinic ACO, LLC (MSSP, ACO ID A1131).

What billing organization is linked to Ajay Mathew, D.O.?

Ajay Mathew, D.O. is linked to OHI WEST MEDICAL GROUP II LLC (billing NPI 1982381299) in the available physician profile data.

Does Ajay Mathew, D.O. have Open Payments data?

Ajay Mathew, D.O. has 45 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.